Majority of Americans support increased federal spending to support cancer ‘moonshot’

The American public has overwhelming confidence in the progress being made in the research and development of treatments to fight cancer, translating into vast support of the Obama administration’s proposal to increase funding for cancer research under the cancer “moonshot” initiative, according to Stat News.

Advertisement

A Recent Stat-Harvard poll found more than eight out of 10 Americans support at least a 20 percent increase in federal spending for cancer research, the amount President Barack Obama proposed for the cancer moonshot. Almost half — 46 percent — said the funding increase is “about right,” and 37 percent said it is not enough, according to the report.

Support for the initiative is largely bipartisan: 90 percent of Democrats and 79 percent of Republicans indicated support for at least a 20 percent increase in federal support for cancer research.

However, Democrats and Republicans have differing views on how exactly that money should be channeled.

President Obama has requested the 20 percent bump, or additional $755 million increase, come from an automatic funding stream called “mandatory spending,” but Republicans say that would enable him to evade the spending limits mandated by federal law. They want to instead give Congress more control in determining where the funding comes from, according to the report.

More articles on finance:
Destination Medical Center in Rochester reports $154M so far in private investments
CBO: Subsidies, taxes and penalties to cost government $660B in 2016
Former Presence CEO: Illinois’ budget woes, malpractice climate contributed to system’s $186M operating loss

Advertisement

Next Up in Financial Management

  • Healthcare leaders are often expected to compartmentalize emotion to make difficult decisions, drive results, and maintain operational focus. For many years, I led…

  • Chicago-based CommonSpirit recorded an operating income of $2 million (0% operating margin) in the second quarter of fiscal 2026, down…

  • Amy Assenmacher, RN, senior vice president of revenue cycle at Grand Rapids, Mich.-based Corewell Health, is confident that healthcare is…

Advertisement

Comments are closed.